Acid Reflux Clinical Trial
Official title:
A Randomised, Three-Period, Single Dose, Open-Label, Crossover Study to Investigate the Relative Bioavailability and Pharmacodynamic Profiles of a Zegerid 20mg Capsule, Zegerid 20mg Powder for Oral Suspension and Losec 20mg Capsule in Healthy Adult Volunteers Under Fasting Conditions
The purpose of this study is to assess the effectiveness of Zegerid 20mg capsules and powder and Losec 20mg capsules in healthy volunteers under fasting conditions.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06241183 -
Famotidine and Antacids for Treatment of Dyspepsia
|
Phase 4 | |
Terminated |
NCT02749071 -
An Investigation of the EndoStim® Lower Esophageal Sphincter (LES) Stimulation System for the Treatment of Reflux
|
N/A | |
Recruiting |
NCT04883567 -
The Use of AI to Improve Quality of OGD
|
||
Completed |
NCT03516188 -
Efficacy of Gaviscon-Advance® in Suppressing Post-supper Acid-pocket and Night-time Acid-reflux in Obese Participants
|
Phase 2/Phase 3 | |
Completed |
NCT01705275 -
A Study to Investigate the Effect of ONO-8539 on Acid-Induced Oesophageal Hypersensitivity in Healthy Volunteers
|
Phase 1 | |
Withdrawn |
NCT02700087 -
In Infants With Laryngomalacia, Does Acid-Blocking Medication Improve Respiratory Symptoms?
|
N/A | |
Completed |
NCT02226484 -
Can Quercetin Increase Claudin-4 and Improve Esophageal Barrier Function in GERD?
|
Phase 1 |